Shari A. Pilon

510 total citations
7 papers, 417 citations indexed

About

Shari A. Pilon is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shari A. Pilon has authored 7 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shari A. Pilon's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (4 papers) and HER2/EGFR in Cancer Research (3 papers). Shari A. Pilon is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (4 papers) and HER2/EGFR in Cancer Research (3 papers). Shari A. Pilon collaborates with scholars based in United States, Netherlands and France. Shari A. Pilon's co-authors include Wei‐Zen Wei, Marie P. Piechocki, Marten Veenhuis, Johannes P. van Dijken, W. Harder and Ye-Shih Ho and has published in prestigious journals such as The Journal of Immunology, Journal of Immunological Methods and Archives of Microbiology.

In The Last Decade

Shari A. Pilon

7 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shari A. Pilon United States	7	238	206	164	131	53	7	417
Cédric Bès France	11	122 0.5×	203 1.0×	41 0.3×	160 1.2×	52 1.0×	16	410
H.G. Seijen Netherlands	11	264 1.1×	118 0.6×	23 0.1×	99 0.8×	36 0.7×	19	402
Tsuguo Kuwata Japan	11	182 0.8×	162 0.8×	105 0.6×	31 0.2×	39 0.7×	31	376
Hannah M. Kerns United States	9	178 0.7×	115 0.6×	55 0.3×	28 0.2×	68 1.3×	10	343
Saori Ishida Japan	8	55 0.2×	136 0.7×	205 1.3×	126 1.0×	20 0.4×	14	421
Jon J. Schmuke United States	11	74 0.3×	238 1.2×	27 0.2×	33 0.3×	36 0.7×	14	373
D. McCool Canada	13	103 0.4×	259 1.3×	27 0.2×	55 0.4×	31 0.6×	14	412
Li Phing Liew United Kingdom	7	87 0.4×	153 0.7×	24 0.1×	74 0.6×	26 0.5×	9	243
Nidia Alvarez-Rueda France	10	89 0.4×	185 0.9×	56 0.3×	94 0.7×	13 0.2×	12	328
Cerottini Jc Switzerland	9	378 1.6×	86 0.4×	61 0.4×	85 0.6×	29 0.5×	20	472

Countries citing papers authored by Shari A. Pilon

Since Specialization

Citations

This map shows the geographic impact of Shari A. Pilon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shari A. Pilon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shari A. Pilon more than expected).

Fields of papers citing papers by Shari A. Pilon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shari A. Pilon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shari A. Pilon. The network helps show where Shari A. Pilon may publish in the future.

Co-authorship network of co-authors of Shari A. Pilon

This figure shows the co-authorship network connecting the top 25 collaborators of Shari A. Pilon. A scholar is included among the top collaborators of Shari A. Pilon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shari A. Pilon. Shari A. Pilon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Pilon, Shari A., et al.. (2003). Broadening of Epitope Recognition During Immune Rejection of ErbB-2-Positive Tumor Prevents Growth of ErbB-2-Negative Tumor. The Journal of Immunology. 170(3). 1202–1208. 38 indexed citations

2.

Piechocki, Marie P., Ye-Shih Ho, Shari A. Pilon, & Wei‐Zen Wei. (2003). Human ErbB-2 (Her-2) Transgenic Mice: A Model System for Testing Her-2 Based Vaccines. The Journal of Immunology. 171(11). 5787–5794. 95 indexed citations

3.

Piechocki, Marie P., Shari A. Pilon, & Wei‐Zen Wei. (2002). Quantitative measurement of anti-ErbB-2 antibody by flow cytometry and ELISA. Journal of Immunological Methods. 259(1-2). 33–42. 35 indexed citations

4.

Pilon, Shari A., Marie P. Piechocki, & Wei‐Zen Wei. (2001). Vaccination with Cytoplasmic ErbB-2 DNA Protects Mice from Mammary Tumor Growth Without Anti-ErbB-2 Antibody. The Journal of Immunology. 167(6). 3201–3206. 61 indexed citations

5.

Piechocki, Marie P., Shari A. Pilon, & Wei‐Zen Wei. (2001). Complementary Antitumor Immunity Induced by Plasmid DNA Encoding Secreted and Cytoplasmic Human ErbB-2. The Journal of Immunology. 167(6). 3367–3374. 62 indexed citations

6.

Piechocki, Marie P., et al.. (2001). Degradation Signals in ErbB-2 Dictate Proteasomal Processing and Immunogenicity and Resist Protection by cis Glycine–Alanine Repeat. Cellular Immunology. 212(2). 138–149. 15 indexed citations

7.

Veenhuis, Marten, Johannes P. van Dijken, Shari A. Pilon, & W. Harder. (1978). Development of crystalline peroxisomes in methanol-grown cells of the yeast Hansenula polymorpha and its relation to environmental conditions. Archives of Microbiology. 117(2). 153–163. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact